Evaluation status available after sign-in
About the journal
Drug Discovery Today is a journal published by Elsevier BV in Netherlands. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,820 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 1878-5832 · 1359-6446
- Country
- Netherlands
- Access
- Not open access / not declared
- Declared publication charge
- 4,820 USD
- Declared peer-review model
- peer_review
- Official website
- https://www.sciencedirect.com/journal/drug-discovery-today
Index listings
- MEDLINE · 2002-01-01
- PUBMED · 2000-10-01
- Indexing
- MEDLINE · PUBMED
- APC
- 4,820 USD
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 90 days received→accepted — computed from PubMed (n=98)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
7745
Last recorded publication year
2026
Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
249
i10-index
4040
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 98%
- ORCID iDs in current deposits
- 53%
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9604391
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Computational Drug Discovery Methods
- Computational Drug Discovery Methods
- Computational Drug Discovery Methods
- Pharmaceutical Economics and Policy
- Nanoparticle-Based Drug Delivery
- Chemical Synthesis and Analysis
- Science, Research, and Medicine
- Advanced Drug Delivery Systems
Show all subjects (75)
- Pharmaceutical Economics and Policy
- Pharmaceutical Economics and Policy
- Biotechnology and Related Fields
- Biotechnology and Related Fields
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- Human auditory perception and evaluation
- Human auditory perception and evaluation
- RNA Interference and Gene Delivery
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- Pharmacogenetics and Drug Metabolism
- Pharmacogenetics and Drug Metabolism
- Pharmacogenetics and Drug Metabolism
- Chemical Synthesis and Analysis
- Chemical Synthesis and Analysis
- Pharmaceutical industry and healthcare
- Synthesis and biological activity
- Biosimilars and Bioanalytical Methods
- Biosimilars and Bioanalytical Methods
- Biotechnology and Related Fields
- Receptor Mechanisms and Signaling
- Advanced biosensing and bioanalysis techniques
- Advanced biosensing and bioanalysis techniques
- Genetics, Bioinformatics, and Biomedical Research
- Genetics, Bioinformatics, and Biomedical Research
- Click Chemistry and Applications
- Nanoparticle-Based Drug Delivery
- Nanoparticle-Based Drug Delivery
- Click Chemistry and Applications
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Science, Research, and Medicine
- Science, Research, and Medicine
- Receptor Mechanisms and Signaling
- Receptor Mechanisms and Signaling
- Animal testing and alternatives
- Bioinformatics and Genomic Networks
- Bioinformatics and Genomic Networks
- Drug Transport and Resistance Mechanisms
- Bioinformatics and Genomic Networks
- Advanced Biosensing Techniques and Applications
- Drug Solubulity and Delivery Systems
- Pharmaceutical studies and practices
- Statistical Methods in Clinical Trials
- Monoclonal and Polyclonal Antibodies Research
- 3D Printing in Biomedical Research
- 3D Printing in Biomedical Research
- Protein Degradation and Inhibitors
- Analytical Chemistry and Chromatography
- Analytical Chemistry and Chromatography
- CRISPR and Genetic Engineering
- CRISPR and Genetic Engineering
- Innovative Microfluidic and Catalytic Techniques Innovation
- Innovative Microfluidic and Catalytic Techniques Innovation
- Alzheimer's disease research and treatments
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Neuroscience and Neuropharmacology Research
- RNA and protein synthesis mechanisms
- RNA and protein synthesis mechanisms
- Biomedical Ethics and Regulation
- Protein Structure and Dynamics
- Protein Structure and Dynamics
- Immunotherapy and Immune Responses
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ